Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Enrollment completed in phase II/III trial of ABX-CBL in steroid-resistant GVHD

July 24, 2002

New CB2 agonists and their use in autoimmune diseases, etc.

July 16, 2002

Abiogen and Philogen collaborate on hepatitis C and tetanus vaccines

July 16, 2002

MedImmune receives FluMist complete response letter

July 15, 2002

Kyorin patents new immunosuppressant proteasome inhibitors

July 11, 2002

Large Scale Biology enters collaboration for developing plant-derived vaccines

July 10, 2002

Immune type-selective proteasome inhibitors identified at Kyorin

July 10, 2002

Aventis Pasteur introduces next-generation Daptacel vaccine

July 8, 2002

E.U. approval for Zenapax in pediatric renal transplantation

July 5, 2002

Phase II trials of FluINsure and StreptAvax begin enrollment

July 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...